Literature DB >> 5906182

[Multiple sclerosis and the autoimmunization process. Treatment by antimitotics].

G Aimard, P F Girard, J Raveau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5906182

Source DB:  PubMed          Journal:  Lyon Med        ISSN： 0024-7790


× No keyword cloud information.
  11 in total

1.  Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.

Authors:  L La Mantia; M Eoli; A Salmaggi; V Torri; C Milanese
Journal:  Ital J Neurol Sci       Date:  1998-02

Review 2.  Cyclophosphamide for multiple sclerosis.

Authors:  L La Mantia; C Milanese; N Mascoli; R D'Amico; B Weinstock-Guttman
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  A double blind study on azathioprine efficacy in multiple sclerosis: final report.

Authors:  C Milanese; L La Mantia; A Salmaggi; M Eoli
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

Review 4.  Role of immunosuppressive therapy for the treatment of multiple sclerosis.

Authors:  James M Stankiewicz; Hadar Kolb; Arnon Karni; Howard L Weiner
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

5.  Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.

Authors:  W H Likosky; B Fireman; R Elmore; G Eno; K Gale; G B Goode; K Ikeda; J Laster; C Mosher; J Rozance
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

6.  Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results.

Authors:  C Milanese; L La Mantia; A Salmaggi; A Campi; C Bortolami; L Tajoli; A Nespolo; F Corridori
Journal:  Ital J Neurol Sci       Date:  1988-02

7.  Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.

Authors:  U Patzold; P Pocklington
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

8.  Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.

Authors:  R E Gonsette; L Demonty; P Delmotte
Journal:  J Neurol       Date:  1977-02-17       Impact factor: 4.849

9.  Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.

Authors:  Francesco Patti; Salvatore Lo Fermo
Journal:  Autoimmune Dis       Date:  2011-03-15

10.  Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.

Authors:  Bruno Brochet; Mathilde S A Deloire; Paul Perez; Timothé Loock; Louise Baschet; Marc Debouverie; Sophie Pittion; Jean-Christophe Ouallet; Pierre Clavelou; Jérôme de Sèze; Nicolas Collongues; Patrick Vermersch; Hélène Zéphir; Giovanni Castelnovo; Pierre Labauge; Christine Lebrun; Mikael Cohen; Aurélie Ruet
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.